Excipient lung disease secondary to intravenous heroin use.
Saved in:
| Title: | Excipient lung disease secondary to intravenous heroin use. |
|---|---|
| Authors: | Colbenson GA; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Kubbara A; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA., Cox CW; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Yi ES; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota, USA., Baqir M; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA baqir.misbah@mayo.edu. |
| Source: | BMJ case reports [BMJ Case Rep] 2022 Apr 21; Vol. 15 (4). Date of Electronic Publication: 2022 Apr 21. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X (Electronic) Linking ISSN: 1757790X NLM ISO Abbreviation: BMJ Case Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1757-790X |
|---|---|
| DOI: | 10.1136/bcr-2021-247763 |
